A comparative analysis of the clinical features of acute and chronic drug-induced liver injury
-
摘要:
目的回顾性对比分析急、慢性药物性肝损伤(DILI)临床特征的异同。方法收集2015年1月-2018年12月在北京大学第一医院感染疾病科诊断为DILl的183例住院患者的临床资料,分为急性组(n=138)和慢性组(n=45)。收集患者基本情况、基础疾病、可疑药物用药史、过敏史、饮酒史、症状体征、实验室检查、影像学检查、肝组织病理检查、治疗、转归等资料。所有诊断为DILI的患者均进行RUCAM、肝损伤类型及严重程度分级评分。符合正态分布的计量资料2组间比较采用t检验,不符合正态分布的计量资料2组间比较采用Mann-Whitney U检验;计数资料2组间比较采用χ2检验; DILI慢性化的影响因素分析采用logistics回归分析。结果中草药导致DILI在急、慢性组的病例数为105 (76. 1%)和33 (73. 3%),抗菌素所致的为15 (10. 9%)和5(11. 1%)。2组患者性别(χ2=4. 774,P=0. 029)、肝损伤类型(χ2=9. 848,P=0. 020)及DILI严重程度分级(χ2=8. 012,P=0. 046)情况比较差异均有统计学意义;慢性组RUCAM评分...
-
关键词:
- 化学性与药物性肝损伤 /
- 疾病特征 /
- 糖皮质激素类
Abstract:Objective To investigate the similarities and differences in the clinical features of acute versus chronic drug-induced liver injury( DILI). Methods Clinical data were collected from 183 patients who were hospitalized and diagnosed with DILI in Department of Infectious Diseases,Peking University First Hospital,from January 2015 to December 2018,and the patients were divided into acute group with 138 patients and chronic group with 45 patients. Related data were collected,including general information,underlying diseases,history of suspected drugs,history of allergy,drinking history,symptoms and signs,laboratory examination,radiological examination,liver biopsy,treatment,and prognosis. Roussel Uclaf Causality Assessment Method( RUCAM) score was determined for all patients diagnosed with DILI,and the type and severity of liver injury were determined. The t-test was used for comparison of normally distributed continuous data between groups,and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between groups; the chi-square test was used for comparison of categorical data between groups; a logistic regression analysis was used to investigate the influencing factors for chronicity of DILI. Results Among the 138 patients in the acute group,105( 76. 1%) had DILI caused by Chinese herbal medicine and 15( 10. 9%) had DILI caused by antibiotics,while among the 45 patients in the chronic group,33( 73. 3%) had DILI caused by Chinese herbal medicine and 5( 11. 1%) had DILI caused by antibiotics. There were significant differences between the two groups in sex( χ2= 4. 774,P = 0. 029),type of liver injury( χ2= 9. 848,P = 0. 02),and severity of DILI( χ2= 8. 012,P = 0. 046);77. 8% of the patients in the chronic group had a RUCAM score of ≤6,while 79. 7% of the patients in the acute group had a RUCAM score of ≥6,and there was a significant difference between the two groups( χ2= 21. 471,P = 0. 002). There were significant differences between the two groups in platelet count( PLT),alanine aminotransferase( ALT),aspartate aminotransferase,direct bilirubin,creatinine,detection rate of ANA,and detection rate of SMA( all P < 0. 05). Compared with the acute group,the chronic group had a significantly longer incubation period and a significantly higher proportion of patients with liver cirrhosis or no response to treatment( all P < 0. 05); there was a significant difference between the two groups in the proportion of patients treated with glucocorticoids( χ2= 27. 109,P < 0. 05) or glucocorticoids combined with azathioprine( χ2= 27. 408,P < 0. 05). A total of 16 patients( 11. 6%) in the acute group and 7( 15. 6%) in the chronic group had autoimmune hepatitis-like DILI; 29 patients in the acute group underwent liver pathological examination,among whom2( 6. 9%) had an unknown cause, while 27 patients in the chronic group underwent liver pathological examination, among whom6( 22. 2%) had an unknown cause. ALT( odds ratio [OR]= 0. 997,95% confidence interval [CI]: 0. 985-0. 999,P = 0. 003) and PLT( OR = 0. 997,95% CI: 0. 986-0. 998,P = 0. 013) were independent predictive factors for chronicity of DILI. Conclusion Compared with acute DILI,chronic DILI is more common in female patients and is difficult to diagnose,with a long incubation period,a higher proportion of patients with cholestasis type,and a higher detection rate of autoantibody,and it requires glucocorticoid and immunosuppressive therapy more and tends to have poorer prognosis. ALT and PLT may be independent predictive factors for the chronicity of DILI.
-
[1]Drug-induced Liver Disease Study Group,Chinese Society of Hepatology,Chinese Medical Association.Guidelines for the management of drug-induced liver injury[J].J Clin Hepato1,2015,31(11):1752-1769.(in Chinese)中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志,2015,31(11):1752-1769. [2]LIANG S,FAN ZP,NIE W,et al.Clinical types and features of chronicity of drug-induced liver injury[J].J Clin Hepatol,2016,32(12):2356-2359.(in Chinese)梁珊,范作鹏,聂巍,等.药物性肝损伤慢性化的临床类型及特点[J].临床肝胆病杂志,2016,32(12):2356-2359. [3]HAYASHI PH,FONl-ANA RJ.Clinical featuresdiagnosis and natural history of drug-induced liver injury[J].Semin Liver Dis,2014,34(2):134-144. [4]XU QL,HE LL,LI C,et al.A clinical study of 516 cases of druginduced liver injury[J].J Bethune Med Sci,2019,17(3):223-225.(in Chinese)徐庆玲,何兰兰,李纯,等.516例药物性肝损伤的临床研究[J].白求恩医学杂志,2019,17(3):223-225. [5]ZHU CW,WANG HN,YUAN JL,et al.Clinical features of druginduced liver injury:An analysis of 445 cases[J].J Clin Hepatol,2018,34(2):354-358.(in Chinese)朱春雾,王海南,袁继丽,等.445例药物性肝损伤的临床分析[J].临床肝胆病杂志,2018,34(2):354-358. [6] MIAO XH.Mechanism of drug-induced liver injury[M]//CHENCW.Drug-induced and toxic liver disease.Shanghai:Shanghai Scientific&Technical Publishers,2002:130-242.(in Chinese)缪晓辉.药物性肝损害机制[M]//陈成伟.中毒与药物性肝病.上海:上海科技出版社,2002:130-242. [7]HUANG CY,LIU YM,HUANG YL,et al.Drug-induced liver injury accompanied by autoimmune phenomena:An analysis of clinical characteristics[J].J Clin Hepatol,2015,31(8):1303-1306.(in Chinese)黄春洋,刘燕敏,黄云丽,等.药物性肝损伤患者伴自身免疫现象的临床特点分析[J].临床肝胆病杂志,2015,31(8):1303-1306. [8]YANG J,YU YL,JIN Y,et a I.Clinica I characteristics of drug-induced liver injury and primary biliary cirrhosis[J].World J Gastroenterol,2016,22(33):7579-7586. [9]JIANG HL,QI YB,ZHANG R,et al.Detection rates of autoantibodies in patients with drug-induced liver injury and their clinical significance[J].J Clin Hepatol,2018,34(1):164-167.(in Chinese)姜红丽,祁亚宾,张睿,等.药物性肝损伤患者自身抗体的检出率及其临床意义[J].临床肝胆病杂志,2018,34(1):164-167. [10]LICATA A,MAIDA M,CABIBI D,et al.Clinical features and outcomes of patients with drug-induced autoimmune hepatitis:A retrospective cohort study[J].Dig Liver Dis,2014,46(12):1116-1120. [11]OH HJ,MOK YM,BAEK MS,et a I.Co-development of autoimmune hepatitis and Sj9gren's syndrome triggered by the administration of herbalmedicines[J].Clin Mol Hepatol,2013,19(3):305-308. [12]BJORNSSON E,TALWALKAR J,TREEPRASERTSUK S,et al.Drug-induced autoimmune hepatitis:Clinical characteristics and prognosis[J].Hepatology,2010,51(6):2040-2048. [13]CASTIELLA A,LUCENA MI,ZAPATA EM,et al.Drug-induced autoimmune-like hepatitis:A diagnostic challenge[J].Dig Dis Sci,2011,56(8):2501-2502. [14]LI FL,HUANG ZG,GE CL,et al.Logistic regression analysis of the clinical characteristics and prognostic factors of drug-induced liver injury[J].J Hepatobiliary Surg,2019,27(4):258-262.(in Chinese)李飞龙,黄赵刚,葛朝亮,等.药物性肝损伤的临床特点及预后因素Logistic回归分析[J].肝胆外科杂志,2019,27(4):258-262. [15]ZHANG XY,CHEN HQ,BAI C,et al.Clinical characteristics and prognosis of drug-induced liver injury[J].Contemp Med,2019,25(7):137-139.(in Chinese)张旭艳,陈慧群,白成.药物性肝损伤的临床特点及其预后评估[J].当代医学,2019,25(7):137-139.
计量
- 文章访问数: 1402
- HTML全文浏览量: 58
- PDF下载量: 724
- 被引次数: 0